Predicting genes likely to be involved in human diseases is an important task in bioinformatics field. Nowadays, the accumulation of human protein-protein interactions (PPIs) data provides us an unprecedented opportunity to gain insight into human diseases. In this paper, we adopt the topological similarity in human protein-protein interaction network to predict disease-related genes. As a computational algorithm to speed up the identification of disease-related genes, the topological similarity has substantial advantages over previous topology-based algorithms. First of all, it provides a global measurement of similarity between two vertices. Secondly, quantity which can measure new topological feature has been integrated into the notion of topological similarity. Our method is specially designed for predicting disease-related genes of single disease-gene family. The proposed method is applied to human protein-protein interaction and hepatocellular carcinoma (HCC) data. The results show a significant enrichment of disease-related genes that are characterized by higher topological similarity than other genes.
Introduction
Mining genes associated with human diseases is an important task in bioinformatics field. It can help in understanding the pathogenic mechanism of diseases. There are two traditional approaches for disease gene discovery: the candidate gene approach [1] and positional cloning via linkage analysis [2] . In the traditional approaches, researchers would need to analyze a large number of genes. This will cost too much man power and resources. There-fore, an efficient algorithm for predicting disease-related genes is needed, which can help researchers narrow down the search scope and speed up the identification process of disease-related genes.
Large-scale molecular interaction networks in humans such as human protein-protein interaction network have just become available in the past three or four years. The large-scale high-throughput experiments have yielded a large amount of PPIs data, such as yeast two-hybrid (Y2H) system [3] and affinity purification followed by mass spectrometry (AP-MS) [4] . More databases are becoming available in recent years. Gandhi et al. [5] have collected over 38,000 human LC (literature-curated) protein interactions in the HPRD database and in OPHID [6] Brown and Jurisica have collected over 90000 human protein interactions. The development of experimental technologies and the availability of more PPIs databases provide an unprecedented opportunity to discover disease-related genes from PPIs network.
Various features and patterns have been exploited to predict disease-related genes, such as sequence features [7] , expression patterns [8] and so on. Recently, some researchers have studied methods based on the topological features in PPIs network [9, 10] . The theoretical basis of these topology-based methods is that genes associated with a particular phenotype or function, such as disease, are not randomly positioned in the network. They tend to exhibit high connectivity, cluster together, and reside in central network locations [11] . More topological features have been discovered and exploited in recent years. Tu et al. [12] found that the degrees of disease genes are significantly higher than other genes in the PPIs network. Oti et al. [9] found that genes neighboring disease related genes were more likely to be also disease related genes. Other methods that measure a variety of topological features have been decribed. Xu et al. [10] developed a classifier in which five quantities were employed to measure five different topological features. The same idea of previous topology-based methods is that measurements of similarity are generally determined by local information of topology. The methods based on local topological information are well-suited to predict genes which are neighbors or next neighbors of known disease genes. However when predicting disease-related genes within a single disease-gene family, neighbors and next neighbors of known disease genes just cover a limited scope of network. For example, there are 73 genes which can be treated as high confidence lung cancer genes 1 . In our PPIs network (LC dataset), there are 3558 genes which are neither neighbors or next neighbors of the 73 known disease gene. To solve this problem, we propose a method which is based on topological similarity [13] . The proposed method has substantial advantages over previous topology-based methods. Firstly, it is global. It depends on the whole graph and allows two vertexes to be similar without sharing neighbors. Secondly, quantity which can measure new topological feature has been integrated into topological similarity. A detailed description of topological similarity and our method is presented in the Methods section. 
Methods

Hepatocellular carcinoma data and human PPIs datasets
In order to evaluate the results of our method, a certain amount of known disease genes are needed. In this paper, hepatocellular carcinoma (HCC) data originating from OncoDB.HCC [14] was employed. OncoDB.HCC is the first comprehensive oncogenomic database for hepatocellular carcinoma (HCC). In this database, researchers compiled a list of 614 significant genes which were selected under following criteria:
• Criterion 1: genes significantly up-or down-regulated in at least three independent HCC microarray/proteomic reports.
• Criterion 2: genes were selected with consistent expression level changes for at least 2 folds in more than 70% patients after reprocessing Stanford HCC microarray data.
• Criterion 3: genes with wet-lab experimental data from previous reports.
We choose 310 genes evidenced by wet-lab experimental results and PPI data and were therefore treated as a high confidence disease-gene set (we call it disease-gene set for convenience). Herein, we propose to provide a detailed explanation as follows. Cancer, similar to common disease, is a disease due to malfunction involing multiple factors. It is very difficult to say with hundred percent certainty that some genes are related to cancer but other genes are not. Although many mutated genes been identified in HCC or other cancers, it is very difficult to conclude that specifically mutated genes are cancer genes. Therefore compiling a list of genes that are are positively cancer genes is a difficult or even impossible task. In OncoDB.HCC, genes which both have additional references from wet-lab animal experiments and human tissue data might be recognized as high confidence cancer genes [14] . Human protein-protein interactions datasets were downloaded from database OPHID [6] . PPIs data of OPHID were collected from three sources: (1) Literaturecurated (LC) interactions; (2) High-throughput experiments (EXP);(3) Interactions predicted from model organisms (PDT), such as Drosophila, Saccharomyces cerevisiae etc. We will focus on proteins that are located in the largest connected network component (main component) because the topological similarity is incalculable for proteins which do not belong to the main component. The total number of unique proteins and disease genes in the main component are listed in Tab. 1. It should be noted that there are 1332 genes which are neither neighbors nor next neighbors of known HCC genes in LC dataset.
Building training samples
In recent studies, researchers have found that there are thousands of essential genes in the human genome, which are different from both disease and non-disease genes. They proposed to divide the gene population into three parts namely essential genes, disease genes, and nondisease genes. Researchers compiled a list of ubiquitously expressed human genes (UEHGs) as an approximation of human essential genes [12] . The number of these essential genes in the main component is also listed in Tab. 1. In the main component of LC network, we exclude disease genes and essential genes from the 9894 proteins and the remaining 8210 genes are called 'control-gene set'. Some genes are randomly selected from the controlgene set. These selected genes are regarded as negative training samples. The "control-gene set" of PDT and EXP datasets can be obtained in the same way. 
The notion of topological similarity
Firstly, we want to introduce the notion of topological similarity which was first proposed by Leicht et al. [13] . In this definition of similarity, vertex is said to be similar to vertex if has any network neighbor that is itself similar to . This definition is apparently recursive, because vertex could also be similar to vertex through any neighbor of . In order to make the results converge to a useful limit, a starting point for the recursion should be provided. The starting point we have selected is to make each vertex similar to itself. Thus the definition of topological similarity has two components: the neighbor term and the self-similarity term. The definition can be written as follows
Here, S is the similarity between gene and gene . A is the iv element of adjacency matrix A. δ is the Kronecker's function
The first term of Eq. (1) is the neighbor term, which is determines whether has any network neighbor that is itself similar to . Parameter φ can be treated as the weight of neighbor term. The second term of Eq. (1) says that a vertex is similar to itself. Parameter ψ can be treated as the weight of the self-similarity term. φ and ψ control the balance between these two components of the similarity. We can write Eq. (1) in matrix form as
where S is the similarity matrix, and S is the ij element of S. Matrix A is the adjacency matrix of the network. I is the identity matrix. Eq. (3) can also be written as
. Because we only consider the relative similarity of different pairs of vertices, Parameter ψ can be safely set to 1. Now, Eq. (3) can be written as
Then we can expand Eq. (4) as a power series
It should be noted that [A ] is equal to the number of network paths of length from to . Eq. (5) gives us a term-by-term interpretation of the topological similarity. The first term denotes that a vertex is similar to itself. The second term denotes that vertices that are immediate neighbors of one another have similarity φ. The third term denotes that vertices that are next neighbors of one another have similarity φ 2 , and so forth. φ represents the weight of paths of length and short paths have higher weight than long paths. In previous research, measurements of similarity are generally determined by local information of topology. From Eq. (5), we can see that, topological similarity is a global measurement of similarity. It is based on the global topology. Not only paths length of 1 or 2, but also paths of any length can contribute to the similarity. Although genes which are functionally related usually locate in one or more modules, the number of known disease genes is so few when predicting diseaserelated genes of single disease-gene family. Neighbors and next neighbors of known disease genes just cover a limited scope of the network. By applying the definition of topology similarity to predict disease genes, some important disease genes that are distant from known disease genes may be found. Our thoughts are tested by hepatocellular carcinoma (HCC) data from OncoDB.HCC. We will discuss it in the Results section. The calculation of the similarity matrix S is achieved by this equation:
Eq. (6) is the final form of deduction and it can be directly used in the algorithm. The deducing process from Eq. (5) to Eq. (6) is beyond the scope of this paper. For more details of deduction, we refer the reader to Leicht et al. [13] . In Eq. (6), D denotes the diagonal matrix having the degrees of the vertices in its diagonal elements:
K is the degree of vertex .λ 1 is the largest eigen-value of matrix A. λ 1 can be calculated after we know the adjacency matrix A. α is a tunable parameter. The effect of the parameter α is to reduce the contribution of long paths relative to short ones. Leicht et al. developed a model and used it to test the performance of topological similarity. Their experience suggested that the measurement results would be closest to the underlying model if α was set to 0.97 [13] . Detailed meaning of parameter α can be found in Leicht et al. [13] . Because the diagonal matrix D includes the information of the degrees of vertices, we will use DSD as the similarity matrix so that our algorithm can cover the feature of degrees. The elements of matrix DSD are initially set to constant 0. If Eq. (6) is iterated a approx. a 100 times, and then a good convergence will be found.
K-nearest neighbors classification algorithm (KNN)
After we get the similarity matrix S, we then seek for the K-highest values of every column, which represent the Knearest neighbors of every gene. In our method, a gene will be predicted to be disease-related genes only if all of the K-nearest neighbors are known disease genes. For example, if the K value is set to 2, it means that a gene will be predicted to be a disease-related gene only if the 2 nearest neighbors are known disease genes.
Results
The validity of topological similarity
In order to prove that topological similarity is an effective measurement which can differentiate disease genes and control genes, we have performed two different statistical analyses. One is to test whether the average level of topological similarity between two disease genes is different from two control genes. Here, we take LC dataset as an example where there are 310 known disease genes in the dataset. After obtaining the similarity matrix S of LC network, the submatrix S D is extracted from S. There are 310 rows and 310 colomns in S D where every row and column of S D corresponds to a disease gene. The ij element of S D represents the topological similarity between disease gene and disease gene . The average topological similarity between two disease genes is calculated by
D denotes the disease-gene set which has 310 disease genes. D is the number of genes in D. S is the average value of elements of matrix S D . We don't consider the similarity between a gene and itself, therefore the diagonal elements are excluded from the sum of matrix elements. We gradually decrease the percentage of disease genes in the submatrix S D . For example, in Fig. 1 (LC dataset), the x-coordinate "90%" denotes that the percentage of disease genes in submatrix S D is reduced to 90%. That means 279 disease genes (90% of D) are randomly sampled from the disease-gene set D. The remaining 31 genes are randomly sampled from the control-gene set which has 8210 control genes. In order to avoid sampling bias, the random sampling is repeated 1000 times and the average values of S are shown in Fig. 1 (LC dataset). The same procedures are also performed on PDT and EXP datasets. The results are shown in Fig. 1 . Because disease genes of single disease-gene family are functionally related, Fig. 1 actually suggests that gene pairs which are functionally related will have higher topological similarity. The decrease of S is a consequence of the decrease of such functionally related genes. In Fig. 1 (LC dataset), the xcoordinate "0%" means that all the 310 disease genes has been replaced by control genes. The values here represent the average topological similarity between two control genes. From Fig. 1 (LC dataset), we can see that the average topological similarity between two disease genes (100%) is more than 10-fold higher than that between two control genes (0%).
Another issue is to test whether the average level of topological similarity between a disease gene and the whole disease-gene set D is different from that between a control gene and D. The average topological similarity between single gene and the whole disease-gene set D is calculated by 
Performance of the classification algorithm
We use the 5-fold cross validation to evaluate the prediction quality of our algorithm. The whole gene population is divided into 5 subsets. Each time, one of the 5 subsets is used as the test set and the other 4 subsets are put together to form a training set. After that, we use the training set to classify the test set. Three quantities are employed to evaluate the prediction quality. These quantities are accuracy, sensitivity and precision. 
In Eq. (9), TP, FP, TN, FN represents true positive, false positive, true negative and false negative. The detailed information of prediction quality is listed in Tab. 3. When the K value is set to 2, in LC dataset, the classification algorithm can correctly recover 72% of known disease genes with a precision of 70%. The corresponding accuracy is 73%. The performance of classification algorithm on PDT and EXP datasets is not as good as that on LC dataset. There are two possible reasons for this. First, our method is based on the topological structure of a network, but the topologies of these three PPIs networks are different. Each network has its own features. For example, in LC network, disease genes communicate with each other more quickly. Researchers also found that there exist a lot of heavily connected disease genes in the LC network [10] . The differences of topologies may be a potential reason for the disparity of performance. Second, in PDT and EXP datasets, the differences between disease-gene set and control-gene set are weaker than those in LC dataset. This may be another important factor which can influence the performance of algorithm.
We adopt the method mentioned in Xu et al. [10] to evaluate the performance of our method. 50%-80% of disease genes are randomly sampled from the original diseasegene set and used as positive training samples. The remaining true disease genes are called "leave-out genes". These leave-out genes are treated as "unknown novel disease genes" and mixed with the negative training samples which are randomly sampled from the control-gene set (discussed in Sec. 2.2). In order to avoid sampling bias, at each percentage, the random sampling is repeated 1000 times and the average values of accuracy, sensitivity, precision are listed in Tab. 4. From Tab. 4, we can learn that the classification algorithm has certain robustness to the changing of positive training samples during 5-fold cross validation and the performance becomes better with the increase of positive training samples. We use the leave-out genes to test the ability of disease gene predicting of our algorithm. In LC network, 50% of disease genes (155 genes) are randomly sampled from the original disease-gene set and used as positive training samples. The remaining 155 disease genes are treated as "unknown novel disease genes" and mixed with negative training samples which are randomly sampled from the control-gene set. It is not appropriate to perform statistical analysis on negative training sample which size is either too large or too small. Therefore, we randomly select 2945 control genes as negative training samples. The classification algorithm is used to predict disease genes from these 3100(155+2945) unknown genes. In Fig. 2b , when the K value is set to 2, on average, among the predicted novel disease genes, 13.5% genes are already listed in the 155 leave-out genes. Before using the method, among the 3100 candidate genes, 5 %( 155/3100) genes are leave-out genes. Therefore we can see about 2.7-fold (13.5/5) enrichment relative to the random prediction. The fluctuation of the dots becomes larger if we adopt more strict restrictions (K=2). This is due to so few known disease genes when dealing with the case of single diseasegene family. Because K=3 is too strict, many disease genes will be excluded. In practical use, we set safely the K value to 2. 
Predicting HCC genes from human PPIs network
Hepatocellular carcinoma (HCC) is one of the major cancers in the world. Every year more than 250 thousand people die of HCC. Mining genes associated with HCC is an important step towards understanding the detailed mechanisms of hepatocarcinogenesis and discovering new target molecules for drugs. In this section we take HCC data from OncoDB.HCC as a biological example and analyze it with our method. We set the K value to 2 and apply the classification algorithm to LC network. 482 genes are predicted to be HCC-related genes. These 482 genes are listed in supplementary materials. Among the predicted HCC genes, some genes have been shown to be evident from experiments or literatures. These genes are listed in Tab. 5. There are three types of evidence: abnormal expression level in HCC, literatures and mammalian experiments (such as murine model of HCC). If a gene has evidential support from one of these sources, the corresponding term will be "YES". From Tab. 5, we can see that, when predicting disease-related genes of single diseasegene family, the proposed method can find out not only genes which are neighbors or next neighbors of known disease genes, but also genes which are neither neighbors nor next neighbors. The detecting scope is the whole network. There are 110 genes listed in Tab. 5 and we hope that information compiled in Tab. 5 can help researchers narrow down the search scope and speed up the identification process of HCC related genes. In Tab. 5b, gene CCR7 is the receptor for the chemokine. It can be found in various lymphoid tissues and activates B and T lymphocytes. CCR7 is reported to be involved in various cancers, such as breast cancer, colon cancer, lung cancer, gastric carcinoma, and thyroid cancer [15] . In gastric carcinoma and lung cancer, CCR7 was found to be associated with lymph node metastasis [16, 17] . In HCC, researchers also found that CCR7 is significantly associated with locally progressed tumors and lymph node metastases [15] . These evidences imply CCR7 as a new disease gene candidate for HCC. CCR7 may be closely related to the process of lymph node metastases existing in various cancers. In Tab. 5b gene BAAT encodes a liver enzyme that catalyzes the conjugation of bile acid with glycine or taurine. It is mainly expressed in fully differentiated and quiescent liver cells. Researchers have found that low expression of BAAT is significantly associated with a decreased probability of survival in HCC patients [18] . Massive and uncontrollable recurrence of HCC tends to occur in the group of patients who have low BAAT expression. BAAT was also found to be a reliable indicator for both survival and recurrence in HCC patients [18] . These evidences suggest that gene BAAT may play a role in the recurrence of HCC. The JAK/STAT signaling pathway plays a central role in principal cell fate decisions, regulating the processes of cell proliferation, differentiation and apoptosis. It has been reported in association with cancer by many researchers [19] [20] [21] . The activation of this pathway may promote the occurance of cancer. In Tab. 5a, nine genes are involved in this pathway. They are JAK2, STAT1, STAT3, STAT5, PIAS1, PIAS4, PTPN11, PIK3R1, and CCND2.
We can see that, most central member of JAK/STAT signaling pathway have been predicted by our method. Among these genes, a structurally abnormal form of JAK2 has been reported in human cancer, and the inhibition of JAK2 may play an important role in the treatment of HCC [21] . STAT1, STAT3, and STAT5 are signal transducer and activator of transcription. Constitutive activation of STAT1, STAT3, and STAT5 has been discovered in various cancer types [22] [23] [24] . Each STAT gene has different functions. STAT1 functions as a tumor suppressor gene [22] , whereas STAT3 and STAT5 have shown to play a role in development and tumor progression [23, 24] . Recently, researchers found that activation of STAT5 was associated with HCC aggressive behavior, it induced HCC invasiveness through Epithelial-mesenchymal transition (EMT) [25] . PIAS1 and PIAS4 are a E3 SUMO-protein ligase and protein inhibitor of activated STAT respectively, and has been reported that these two genes will influence the ability of tumor suppressor p53 PIAS1 may involve in the Sumoylation of p53 [26] , PIAS4 inhibited the DNA-binding activity of p53 in nuclear extracts and blocked the ability of p53 to induce expression of two of its target genes [27] . It is well known that p53 is an important tumor suppressor, the dysfunction of p53 will cause various cancers [28] . So PIAS1 and PIAS4 may have influence on cancer via gene p53. PTPN11 is widely expressed in most tissues and plays a regulatory role in various cell signaling events.
Researchers have found a class of PTPN11 mutants which shown oncogenic activity in Hepatocellular carcinoma [29] . Gene PIK3R1 is a subunit of PI3K (Phosphatidylinositol-3-kinase). Evidences from literatures have shown that proper liver function and development depend on intact PI3K signal transduction. When dysregulated, the PI3K pathway is linked to the development of hepatocellular carcinoma [30] . Protein encoded by CCND2 will form a complex and function as a regulatory subunit of gene CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. CCND2 is discovered to be involved in various cancers [31] , abnormal expression level of CCND2 has also been observed in Hepatocellular carcinoma [32] . Evidences described above suggest that these nine genes may be potential HCC candidate genes and the JAK/STAT signaling pathway may play a more important role in the progression of HCC than previously thought.
Discussion
The availability of large-scale molecular interaction networks in humans such as PPIs network provides an opportunity to understand the basis of human diseases. In this paper, we proposed a topological similarity-based method which is designed to predict disease-related genes from single disease-gene family. Topological similarity has substantial advantages over previous topology-based methods. First, it has a transparent theoretical rationale. Topological similarity can gather information from the whole graph, and gives a global measurement of similarity between two vertices. It allows candidate genes and known disease genes to be similar without sharing neighbors. Secondly, quantity which can measure a new topological feature has been integrated into topological similarity, such as the number of paths of any given length.
In the notion of topological similarity, vertices that have many paths of a given length are considered more similar than those that have few. From the results, we can see that topological similarity is an effective measurement in differentiating disease genes and control genes (Sec. 3.1), and there is a 2.7-fold higher likelihood of disease gene prediction than random prediction when the K value was set to 2 ( Fig. 2 ).
There is still ample room to develop our topology-based methods. First, there is practical limitation to method based on single pattern or feature. A promising way to improve the prediction is to integrate various patterns, such as sequence features and expression patterns. We believe that method based on various patterns can enhance the difference between disease genes and non-disease genes. Secondly, methods which can integrate various large-scale biological datasets are needed in the future. However researchers need to develop methods which can extract useful information from different kinds of largescale data sets and properly handle the difference among them. With the development of large-scale experimental technologies, we believe that the accuracy of disease genes prediction will become better.
